Likewise, in cutaneous squamous cell carcinoma, the inhibition of CD147, by using a chimeric anti-CD147 monoclonal antibody or a small interfering RNA against CD147, causes the reduction of EGFR [36]. This evidence concerns the gene BSG and cutaneous squamous cell carcinoma.